TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Proportion of patients meeting ASAS 40 response criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Male partner HIV testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Linkage to ART
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tolerance of apoptotic cells injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in whole body composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in HDL cholesterol efflux capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in faecal microbiota composition and function (carbohydrate metabolism)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Interincisal Space
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: joint response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: steroid free joint response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peribuccal lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of composite neonatal outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of neurofilament light chain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Breslow Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hamilton Anxiety Rating Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in IMR value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fractional plasma volume (vp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fractional extravascular-extracellular space volume (ve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Model-free initial area under the contrast agent concentration curve (iAUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of AE/SAE/AESI
Endpoint domain: Adverse events/effects
Primary endpoint: Sustained cannabis abstinence for 28-days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in UPSIT Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of bruising
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Duration of bruising
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Drug concentration in maternal plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug concentration in maternal breastmilk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug concentration in infant plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of hyponatremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Electrolyte and metabolic outcomes
Primary endpoint: Change in atopic dermatitis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Fatigue Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Crystalloid volume administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type of crystalloid administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ischemic Risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of Life Scale for Employees - Compassion Fatigue Sub-Dimension
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: number of patients who develop unanticipated severe toxicity events
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment Engagement and Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Illness Remission & Treatment Maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnostic accuracy of MSOT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Computed Tomography (CT) mucus score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in maximum level of pain during sport activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apley test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Y Balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Routinely analysed markers for protein intake/compliance - urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Routinely analysed markers for protein intake/compliance - blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: aortic growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Selective motor control of lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trunk muscles performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of participants achieving MCID in VAS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants reporting Treatment-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Mean number cigarettes smoked per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quit status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days to smoking relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of reintubation or respiratory failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Care needs scale for parents of children with Tourette Syndrome (CNS-PCTS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parent-Child Relationship Quality Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Eating Disorder Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Glomerular basement membrane (GBM) width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mesangial expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of subjects achieving sPGA 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Stress reactivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of adverse events (AEs) and serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with clinically significant cognitive or functional worsening of Alzheimer's Disease
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Six Minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance of metabolite and differential enzyme expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentages of individual immune cell populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Active external rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of antimicrobial prescriptions adherent with prescribing guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recruitment of student ambassadors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention of student ambassadors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: School personnel satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to wound bed granulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episode of clot retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Requirement of blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Re-operation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of re-admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to the intervention strategy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pressure Ulcer incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in IL-1β Levels Due to ACE Inhibitors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in TNF-α Levels Due to ACE Inhibitors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in CRP Levels Due to ACE Inhibitors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Modulation of MCP-1 Levels Due to Statin Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Modulation of MIP-1α Levels Due to Statin Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the Concentration-Time Curve from Time 0 to Infinity (AUC0-Inf) of Digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Remaining on Therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in social communication and restricted repetitive behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: proportion of responder patients defined by serum calcium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-Combat PTSD Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients achieving weight loss of ≥5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary dickkopf-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Atrial fibrillation yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Paranoid thoughts
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in BCVA letter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal and Choroidal Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of laparoscopic TEP hernia repairs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Healthy Plant-based Diet Index (hPDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen saturation achieved (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and proportion of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Stone-free Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urological outcomes
Primary endpoint: SNOT-22 total score change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Major complications within 90 days
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Speed during squat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Power during squat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of SARS-CoV-2 specific CD8 T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: school readiness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Posttraumatic Stress Disorder Checklist PCL-5 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite of cardiovascular mortality or type 1-4 bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Change in Alcohol Use over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Alcohol Craving over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Community Functioning over Time
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Best spectacle-corrected distance visual acuity (BCDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Elidah device treatment on urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Vaccine administration rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent With Follow-up Suicidal Behaviors
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Follow-up Suicidal Behaviors
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and case number of DLT (Dose Limiting Toxicity)
Endpoint domain: Adverse events/effects
Primary endpoint: Alveolar crest distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vestibular bone wall thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxic metal ion levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in parent empowerment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brown adipose tissue perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composition of microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral Blood Flow under Normoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebral Blood Flow under Hyperoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 4-Stair Climb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 100-Meter Timed Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PERFORMANCE OF UPPER LIMB 2.0 (PUL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAND HELD DYNAMOMETRY (HHD) AND GRIP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIMED UP-AND-GO (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measures of Pulmonary Function (Seated and supine FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average Fatigue Severity
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Delivered CRRT dose-intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 h Post-operative pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 h Post-operative dynamic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedative effects measured by modified observer's assessment of alertness/sedation scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental separation anxiety scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dysautonomia Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of F-18 FNT-PET in prediction of clinical decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of the safety of F-18 FNT using adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of Apnea Hypopnea Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients with a ≥3-point reduction in peak pelvic pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with no increase in the number of standard pain relief medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who decide to enroll in a neuroblastoma clinical trial
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of patients who remain in neuroblastoma clinical trial to trial completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency of compensatory behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain observation by image
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resolution of status epilepticus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in IES-R score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neurologic disability free survival
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of CV adverse events leading to drug discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of life threatening and fatal cardiac events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of grade≥3 Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in anxiety (measured by STAI-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in alcohol craving (measured by YCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mood disturbance (measured by DEQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Recall Anesthesia Team Members
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Recall Anesthetic Risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative Understanding of Anesthetic Plan
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of treatment emergent adverse events leading to intervention discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients who need hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of patients deceased before 14 days of initiating treatment
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients deceased before 30 days of initiating treatment
Endpoint domain: Mortality/survival
Primary endpoint: burden of MMN on participants' quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: change in pancreatic parenchymal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of postoperative pancreatic fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Neurologic prognosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with invasive fungal infection
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in scores on the Physical functioning subscale of the Pediatric Quality of Life Inventory (PedsQL) over time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average CBD dose used in the titration phase
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average CBD dose used in the maintenance phase
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Severity of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients reporting Drug-Induced Liver Injury
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of severity of depression symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants reporting suicidal ideation and behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in serum level of total protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in ocular symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in muscle stiffness of the pectoralis major
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ambulatory 24-hour average SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Local recurrence free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in Suicidal Ideation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes